Volume 23, Number 12—December 2017
Research
Characterization of Streptococcus pyogenes from Animal Clinical Specimens, Spain
Table 2
Testing results for the 15 isolates characterized in study of Streptococcus pyogenes from animal specimens, Spain*
Isolate |
emm type |
PFGE profile |
MLST type |
MIC, mg/L | Macrolide resistance | TET resistance genes |
Virulence genes |
||||
---|---|---|---|---|---|---|---|---|---|---|---|
ERY |
CLIN |
TET |
Phenotype |
Genotype |
|||||||
M50163 | 12 | A | ST36 | >256 | 32 | 96 | cMLSB | mefA/ermB | tetM/tetO | speB/speF/speG | |
M79144 | 12 | A | ST36 | >256 | 0.75 | 48 | M | mefA/ermB | tetM/tetO | speB/speF/speG | |
M78761 | 12 | A | ST36 | >256 | 0.75 | 32 | M | mefA/ermB | tetM/tetO | speB/speF/speG | |
M75791 | 12 | A | ST36 | 6 | 0.09 | 32 | M | mefA/ermB | tetM/tetO | speB/speF/speG | |
M75539 | 12 | A | ST36 | 8 | 0.19 | 24 | M | mefA/ermB | tetM/tetO | speB/speF/speG | |
M75533 | 12 | A | ST36 | 16 | 0.19 | 32 | M | mefA/ermB | tetM/tetO | speB/speF/speG | |
M75123 | 12 | A | ST36 | 12 | 0.19 | 48 | M | ermB | tetM/tetO | speB/speF/speG | |
M73512 | 12 | A | ST36 | 0.25 | 0.12 | 32 | tetM/tetO | speB/speF/speG | |||
M72636 | 12 | A | ST36 | >256 | >256 | 48 | cMLSB | ermB | tetM/tetO | speB/speF/speG | |
M72193 | 12 | A | ST36 | >256 | 1.5 | 96 | iMLSB | ermB | tetM/tetO | speB/speF/speG | |
83639 | 12 | A | ST36 | >256 | 0.38 | 48 | M | ermB | tetM | speB/speF/speG | |
83553 | 77 | B | ST63 | 0.19 | 0.12 | 64 | speB/speF/spec | ||||
85374 | 77 | B | ST63 | 0.12 | 0.09 | 64 | tetO | speB/speF/spec | |||
M75768 | 77 | B | ST63 | 0.12 | 0.09 | 32 | tetM/tetO | speB/speF/speC | |||
M82209 | 77 | B | ST63 | 0.19 | 0.12 | 64 | tetO | speB/ speF/speC |
*ERY, erythromycin; CLIN, clindamycin; MLST, multilocus sequence typing; PFGE, pulsed-field gel electrophoresis; ST, sequence type; TET, tetracycline.